+8.7%
VICI vs GSK
+47.2%
-38.5%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | 0.0% | +0.4% | +0.4% |
| 7D | -2.3% | -3.5% | +1.2% | -1.5% |
| 30D | -4.8% | -3.4% | -1.3% | -4.0% |
| 3M | -10.1% | -8.1% | -2.0% | -8.4% |
| 6M | -9.7% | -11.1% | +1.4% | -7.4% |
| YTD | -8.8% | +0.7% | -9.5% | -9.1% |
| 1Y | -20.2% | +20.1% | -40.4% | -23.9% |
| 3Y | -5.8% | +46.1% | -51.9% | -15.8% |
| All | +8.7% | +47.2% | -38.5% | -6.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling